Skip to main content

Table 2 Odds ratios (OR) for immunological non-response in patients on successful HAART for more than three years.

From: Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study

Characteristics OR Un-adjusted (95% CI*) OR, Adjusted ** (95% CI)
Male gender 2.18 (0.94 - 5.09) 1.73 (0.73 - 4.14)
More than 40 years old at index date 2.53 (1.390 - 4.63) 2.32 (1.25 - 4.29)
Caucasians 2.23 (1.01 - 4.98) 1.09 (0.36 - 3.36)
Route of HIV infection   
   Men who have sex with men 1.0  
   Heterosexually infected 0.48 (0.24 - 0.96) 0.73 (0.30 - 1.78)
   Injection drug user 1.67 (0.63 - 4.54) 3.06 (0.98 - 9.52)
   Other 0.62 (0.22 - 1.75) 0.63 (0.20 - 1.96)
Chronic HCV infection 1.84 (0.76 - 4.43) 2.11 (0.79 - 5.61)
Cancer within 13 years prior to index date 1.72 (0.78 - 3.81) 1.47 (0.63 - 3.44)
One or more AIDS defining events prior to index date 0.83 (0.46 - 1.50) 0.84 (0.46 - 1.53)
Diagnosed with HIV before 1 January 1995 1.46 (0.81 - 2.63) 1.43 (0.72 - 2.86)
Nadir CD4 cell count less than 50 cells/μL 1.59 (0.86 - 2.96) 1.06 (0.43 - 1.75)
More than one year from first CD4 ≤ 200 cells/μL to start of the virologically suppressed period 2.03 (1.12 - 3.68) 2.28 (1.18 - 4.43)
  1. *Confidence interval (95%CI).
  2. **All estimates adjusted for age and gender.